ReviewCureus2019

The Use of Epidermal Growth Factor Receptor Type 2-Targeting Tyrosine Kinase Inhibitors in the Management of Epidermal Growth Factor Receptor Type 2-Positive Gastric Cancer: A Narrative Review.

Asim M AlMazmomy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.